OpenAlex
PricingAboutJobs
Log inGet started
Work

What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?

HTML

Year: 2007
Type: editorial
Source: Gynecologic Oncology
DOI: 10.1016/j.ygyno.2007.01.038
Authors: E HAN, B MONK
Institutions: University of California, Irvine, University of California, Irvine Medical Center, UC Irvine Chao Family Comprehensive Cancer Center
Language: English

Topic: Ovarian cancer diagnosis and treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: bevacizumab, intestinal perforation, ovarian cancer, tumor angiogenesis, vascular endothelial growth factor, hypoxia-inducible factor-1α, adverse drug reactions, anti-angiogenic therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1973183162
Cites: 25
Cited by: 169
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms